1. Introduction {#sec1}
===============

Reperfusion arrhythmias (RA) are the main complications of cardiopulmonary bypass (CPB) in heart surgery. Arrhythmias, such as ventricular tachycardia and ventricular fibrillation, can induce hemodynamic disorders and sudden cardiac death \[[@B1], [@B2]\]. In the study of arrhythmias, monophasic action potentials (MAPs) is an indicator for changes of cardiac vectors of cardiac arrhythmias, which can describe the repolarization phase of cardiac myocytes intuitively and steadily, and MAPs is an important means to observe the electrical activity of cardiac myocytes \[[@B3], [@B4]\]. The action potential duration recorded by the single-phase action potential synchronous recording technique is closely related to arrhythmia.

Studies have shown that sevoflurane can reduce the incidence of RA \[[@B5]--[@B7]\], but it is not clear whether sevoflurane can affect MAPs in ischemia-reperfusion myocardium. This study is aimed to explore the effects of sevoflurane on the MAPs in an isolated rat heart of ischemia-reperfusion by synchronous recording in the endocardium and epicardium of cardiac myocytes.

2. Materials and Methods {#sec2}
========================

2.1. Animals {#sec2.1}
------------

Healthy male SD rats weighing 280 to 320 g were kept in standard transparent polyethylene cages in a light cycle (darkness of 12 h--light of 12 h) in an animal room at 22°C. They had free access to water and food until the time of test. All experiments were approved by the Institutional Animal Care and Use Committee of Guizhou Medical University, and conducted in accordance with the Guide for the Care and Use of Laboratory Animals.

2.2. Preparation of Krebs--Henseleit Solution {#sec2.2}
---------------------------------------------

Krebs--Henseleit (K--H) fluid and Thomas solution was freshly prepared before each test. The components of the solution (mmol/l) included sodium chloride (118.5), sodium bicarbonate (25), potassium chloride (4.8), magnesium sulfate (1.2), D-glucose (12), potassium dihydrogen phosphate (1.2), and calcium chloride (1.7). Thomas solution (g/l) contained sodium chloride (6.44), potassium chloride (1.2), magnesium chloride (1.52), sodium bicarbonate (0.83), and calcium chloride (0.14). All of these components were dissolved in distilled water, but calcium chloride was added after all the ingredients to prevent precipitation.

2.3. Surgical Procedure for Isolated Heart Preparation {#sec2.3}
------------------------------------------------------

The animals were pretreated with intraperitoneal injection of 300 IU heparin and then anaesthetized by sodium pentobarbital (50--60 mg/kg). After sacrifice of the animals, their hearts were excised rapidly and mounted on a nonrecirculating Langendorff apparatus under a constant pressure of 80 mmHg at 37°C and perfused with K--H solution that previously equilibrated with 95% O~2~ and 5% CO~2~ (pH = 7.4).

2.4. Study Protocols {#sec2.4}
--------------------

In preparation of the hearts as well as the Langendorff setup, we followed the methods of Haghi et al. \[[@B8]\]. The rat hearts were randomly divided into three groups after successful preparation of the Langendorff isolated heart perfusion model and 15 min balanced perfusion of K--H fluid. In the control group (group A), K--H fluid was under continuous perfusion for 105 min. In the ischemia-reperfusion group (group B), K--H fluid was stopped after continuous balanced perfusion for 15 min and cardiac arrest of global ischemia was induced for 60 min with the perfusion of Thomas solution (4°C, 20 ml/kg), while the heart was protected by the low temperature Thomas solution (4°C) around it. Reperfusion of Thomas solution (4°C, 10 ml/kg) was performed for 30 min, and the heart was resuscitated by the perfusion of K--H fluid for 30 min. In the sevoflurane group (group C), K--H fluid contained 1.0 MAC sevoflurane, and other procedures were same as in group IR. The K--H fluid was equilibrated with sevoflurane using Vapor2000 with an air bubbler. The concentration of sevoflurane was also measured in the buffer before entering the aortic cannula using a volatile anesthetic gas monitor.

2.5. MAPs Recording {#sec2.5}
-------------------

MAPs was recorded by a custom-made electrode, which could record the MAPs of the epicardium (Epi) and endocardium (Endo) simultaneously. The MAPs signals were amplified and recorded with a biological signal collecting and processing system. HR and MAPs including time course (MAPD~50~ or MAPD~90~) of endocardium and epicardium were recorded at the time of balance perfusion for 15 min (*T*~0~), continuous perfusion for 15 min (*T*~1~), reperfusion for 15 min/continuous perfusion for 105 min (*T*~2~), and reperfusion for 30 min/continuous perfusion for 120 min (*T*~3~), and transmural dispersion of repolarization (TDR) was calculated. The incidence of arrhythmia, time for restoration of spontaneous heart beat, and duration of arrhythmia were recorded during the period of reperfusion.

2.6. Arrhythmias Analysis {#sec2.6}
-------------------------

Based on the Lambeth conventions \[[@B9]\], the MAPs were analyzed to determine the number of single ectopic beats, salvos (couplets and triplets), ventricular tachycardia (VT), the total number of ventricular ectopic beats (VEBs), incidence, and duration of VT during the 30 min of reperfusion time.

2.7. Statistical Analysis {#sec2.7}
-------------------------

Statistical analyses were performed using the SPSS18.0 software. Except for the arrhythmia scores, the other data are expressed as mean ± SD after test for normality. The comparison between groups was carried out by using one-way analysis of variance. Pairwise comparison was carried out using the LSD method. The *X*^2^-test was used for enumeration data, and values of *P* \< 0.05 were considered statistically significant.

3. Results {#sec3}
==========

3.1. Effects of Sevoflurane on Heart Rate (HR) and Transmural Dispersion of Repolarization (TDR) in I/R Rats {#sec3.1}
------------------------------------------------------------------------------------------------------------

HR in group B and group C was lower at *T*~2~ and *T*~3~ than that in group A, while it in group B was significantly lower than that in group A at *T*~2~ and *T*~3~, and HR in group C was higher than that in group B at *T*~2~ and *T*~3~ (*P* \< 0.05, [Table 1](#tab1){ref-type="table"}). There was no difference of TDR in each group at *T*~0~ and *T*~1~ (*P* \> 0.05), while TDR in group B was increased at *T*~2~ and *T*~3~ compared with that in group C and group A (*P* \< 0.05). TDR in group C was decreased compared with that in group B at *T*~2~ and *T*~3~ (*P* \< 0.05), while there was no such difference between group C and group A (*P* \> 0.05, [Table 1](#tab1){ref-type="table"}).

3.2. Effects of Sevoflurane on Reperfusion Arrhythmia (RA) in I/R Rats {#sec3.2}
----------------------------------------------------------------------

Arrhythmia scores in group B was higher than that in group C, while the time for restoration of spontaneous heart beat and duration of arrhythmia in group C were shorter than that in group B (*P* \< 0.05, [Table 2](#tab2){ref-type="table"}).

3.3. Effects of Sevoflurane on MAPs in I/R Rats {#sec3.3}
-----------------------------------------------

There was no difference of MAPD~50~ in each group (*P* \> 0.05, [Table 3](#tab3){ref-type="table"}). The MAPD~90~ in group B was much longer than that in other groups at *T*~2~ and *T*~3~ (*P* \< 0.05), while there was no such difference between group C and group A (*P* \> 0.05). The prolonged MAPD~90~ at *T*~2~ and *T*~3~ in group B strikingly differed from that at *T*~0~ and *T*~1~ (*P* \< 0.05). Nevertheless, there was no such difference in other groups at different time points (*P* \> 0.05, [Table 3](#tab3){ref-type="table"}).

4. Discussion {#sec4}
=============

Langendorff isolated perfused heart model, which may reveal pathophysiological changes in the heart more accurately compared to tissue and cells and eliminate the negatives of neurohumoral factors and the preload and after load of heart \[[@B10]--[@B12]\], was used in this study for a favorable assessment for the MAPs on ischemia-reperfusion isolated heart by sevoflurane.

Our results showed that sevoflurane could shorten MAPD~90~ of ischemia-reperfusion myocardium and decrease TDR and the incidence of reperfusion arrhythmias and the time for restoration of spontaneous heart beat and duration of arrhythmia. Lee showed sevoflurane can prolong the QT interval and QTc interval \[[@B13]\], and Gong found that sevoflurane can lengthen APD of single cardiomyocyte under normal physiological conditions \[[@B14]\]. While our study revealed that MAPD~90~ prolonged after ischemia-reperfusion and sevoflurane could shorten it, these all suggested that sevoflurane directly played a role in ameliorating the myocardial repolarization in isolated rat hearts after ischemia-reperfusion.

In the study of arrhythmia, MAPs, an indicator of vector cardiograph for a population of cells, could record myocardial repolarization intuitively, especially after myocardial depolarization \[[@B15], [@B16]\]. Therefore, it has been regarded as an effective method for the detection of the electrical activity of cardiomyocytes and pharmacologically electrophysiological exploration \[[@B17], [@B18]\]. Monophasic action potentials could avoid the heterogeneity from different origins. We ensured that MAPs were derived from the same transmural origin. In this way, the sevoflurane effects on each myocardium layer were investigated apart from the evaluation of myocardial repolarization.

Various ion channel currents are involved in cardiac action potential, but the APD is determined by outward and inward currents \[[@B19], [@B20]\]. MAPD~50,~ where ICa-L, Ikr, and Iks are involved, largely reflects plateau of action potential \[[@B21]\]. APD could be prolonged when the Ca^2+^ inward current increases, which is liable to cause arrhythmia and early after depolarization \[[@B22]\]. The action potential repolarization could be prolonged when Ikr and Iks are inhibited \[[@B23]\]. Iks, a ventricular myocardium repolarization reserve and a remarkable prolonged APD, will present in appearance of suppressed Iks \[[@B24]\]. MAPD~90~ is a representative of phase 3 where mainly mediated by Ikr and Ik1 \[[@B25], [@B26]\]. These two are the currents which are responsible for the early stage and late stage of phase 3, respectively \[[@B27], [@B28]\]. The prolonged MAPD~90~ shows that when inhibited, Ikr and Ik1 slow down K^+^ current rate. TDR reflects the nonuniformity of ventricular myocyte repolarization of myocardial layers. The increased TDR is the basic factor of a variety of malignant arrhythmia, especially polymorphic ventricular tachycardia and torsades de pointes ventricular tachycardia. Therefore, sevoflurane may alter MAPs through influencing icon channels.

5. Conclusion {#sec5}
=============

In summary, we found sevoflurane could alleviate reperfusion arrhythmia by ameliorating TDR and MAPD~90~ in isolated rat hearts after ischemia-reperfusion.
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###### 

Effects of sevoflurane on heart rate (HR) and transmural dispersion of repolarization (TDR) in I/R rats (*n* = 8, $\overline{x} \pm s$).

  Parameters       Group           *T* ~0~         *T* ~1~             *T* ~2~             *T* ~3~
  ---------------- --------------- --------------- ------------------- ------------------- ---------------
  HR (beats/min)   A               241.00 ± 4.78   240.00 ± 3.51       240.63 ± 4.84       243.57 ± 5.10
  B                243.12 ± 3.09   241.12 ± 3.09   172.63 ± 5.58^ab^   181.75 ± 7.67^ab^   
  C                242.55 ± 2.82   244.25 ± 2.12   231.62 ± 2.92^bc^   230.13 ± 2.23^bc^   
                                                                                           
  TDR (ms)         A               3.81 ± 1.25     3.64 ± 1.88         3.86 ± 0.96         3.47 ± 1.38
  B                3.90 ± 1.16     3.82 ± 1.69     5.91 ± 1.06         6.10 ± 1.53         
  C                3.32 ± 1.18     3.58 ± 1.27     3.58 ± 1.31^a^      3.76 ± 1.56^a^      

Note: compared with the *T*~0~, ^a^*P* \< 0.05; compared with the *T*~1~, ^b^*P* \< 0.05; compared with group B, ^c^*P* \< 0.05.

###### 

Comparison of time for restoration of spontaneous heart beat, arrhythmia duration, and arrhythmia scores in two groups.

  Group   *N*   Time for restoration of heart beat (*s*, $\overline{x} \pm s$)   Arrhythmia duration (min, $\overline{x} \pm s$)   Arrhythmia scores (score, *M* (*Q*))
  ------- ----- ---------------------------------------------------------------- ------------------------------------------------- --------------------------------------
  B       8     23.60 ± 5.16                                                     6.82 ± 1.69                                       0.50 (2.00)
  C       8     12.42 ± 4.78^a^                                                  3.28 ± 1.71^a^                                    0.00 (1.50)^a^

Note: compared with group B, ^a^*P* \< 0.05.

###### 

Comparison of MAPs among three groups at different time points (ms, $\overline{x} \pm s$, *n* = 8).

  Parameters   Sites          Group          *T* ~0~           *T* ~1~           *T* ~2~        *T* ~3~
  ------------ -------------- -------------- ----------------- ----------------- -------------- --------------
  MAPD~50~     Epi            A              17.71 ± 1.95      16.64 ± 2.88      16.06 ± 3.76   17.87 ± 2.38
  B            17.50 ± 3.16   16.22 ± 1.68   16.11 ± 2.56      17.10 ± 2.53                     
  C            17.32 ± 3.16   15.08 ± 2.28   17.08 ± 4.24      17.76 ± 2.56                     
  Endo         A              18.80 ± 2.19   16.03 ± 0.73      15.34 ± 3.67      16.00 ± 3.58   
  B            18.94 ± 0.96   16.43 ± 4.88   15.33 ± 3.97      17.50 ± 3.94                     
  C            18.17 ± 2.86   15.85 ± 3.05   18.90 ± 3.64      17.89 ± 3.82                     
                                                                                                
  MAPD~90~     Epi            A              34.71 ± 3.95      33.64 ± 2.88      33.86 ± 3.76   32.87 ± 2.38
  B            33.50 ± 3.16   34.22 ± 1.68   47.11 ± 2.56      45.10 ± 2.53                     
  C            34.32 ± 3.16   33.08 ± 2.28   39.08 ± 4.24^a^   37.76 ± 2.56^a^                  
  Endo         A              39.80 ± 2.19   36.03 ± 0.73      35.34 ± 3.67      36.62 ± 3.58   
  B            39.94 ± 2.96   35.43 ± 4.88   47.33 ± 3.97      47.50 ± 3.94                     
  C            39.17 ± 2.86   35.85 ± 3.05   39.90 ± 3.64^a^   37.89 ± 3.82^a^                  

Note: compared with group B, ^a^*P* \< 0.05.
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